The major side effect of colchicine is gastrointestinal distress, particularly diarrhea. This is the most common complaint among people taking the drug for gout, familial Mediterranean fever, or pericarditis, and it often appears before the medication has fully controlled the condition it was prescribed for. While diarrhea is the most frequent problem, colchicine carries a narrow therapeutic index, meaning the gap between a helpful dose and a harmful one is unusually small. That narrow margin makes understanding all of its potential side effects especially important.
Why GI Problems Are So Common
Colchicine works by interfering with a structural component inside cells called microtubules. These tiny scaffolding structures are essential for cell division, and colchicine binds to their building blocks, preventing them from assembling properly. The cells lining your digestive tract are among the fastest-dividing cells in your body, which makes them particularly vulnerable. The result is nausea, vomiting, abdominal cramping, and diarrhea, sometimes severe enough that people stop taking the medication on their own.
These symptoms typically begin within hours of taking a dose that’s too high or that your body can’t clear efficiently. For most people on a properly adjusted dose, GI side effects are mild and manageable. But because colchicine’s therapeutic window is so tight, even small changes in how your body processes the drug can push you from “tolerable” into “miserable.”
Muscle Weakness and Nerve Damage
A less common but more serious side effect is colchicine-induced myopathy, a form of muscle damage. Colchicine can disrupt the internal structure of muscle fibers, leading to progressive weakness, muscle pain, and fatigue. This risk increases the longer you take the drug, particularly if you have kidney problems that slow its elimination from your body.
In some cases, colchicine also affects nerves, producing a combined condition called neuromyopathy. Symptoms include tingling or numbness in the hands and feet alongside muscle weakness. Blood tests may show elevated levels of an enzyme called creatine kinase, which leaks out of damaged muscle cells. Screening for this with blood work every six months is recommended for people on long-term colchicine who also have reduced kidney function.
Blood Cell Suppression
Because colchicine targets rapidly dividing cells, it can also suppress bone marrow, the tissue responsible for producing blood cells. This can lead to dangerously low white blood cell counts, low platelet counts, or in rare cases, a condition where the marrow stops producing cells altogether. The signs include unexplained bruising, unusual bleeding, persistent fatigue, and frequent infections. This type of toxicity is more likely at higher doses or when the drug accumulates in the body due to impaired kidney or liver function.
The Narrow Therapeutic Window
What makes colchicine riskier than many medications is that the dose needed to treat your condition sits uncomfortably close to the dose that causes harm. There is no large safety cushion. This is why dose adjustments matter so much for people with kidney problems. If your kidneys can’t clear the drug efficiently, it builds up in your blood and tissues even at standard doses.
For people with severely reduced kidney function, starting doses are typically cut in half or more. People on dialysis require even further reductions, with gout flare treatments limited to a single low dose that cannot be repeated for at least two weeks. Even people with mild to moderate kidney impairment need close monitoring, because the line between effective and toxic can shift without obvious warning.
Drug Interactions That Increase Toxicity
Colchicine is broken down in the body through two pathways: a liver enzyme system and a protein that pumps drugs out of cells. Several common medications block one or both of these pathways, causing colchicine levels to spike. The combination has caused life-threatening toxicity and deaths.
The most dangerous interactions involve drugs that block both pathways simultaneously. Clarithromycin, a widely prescribed antibiotic, is a well-known example. Other medications that raise colchicine levels include:
- Erythromycin, another common antibiotic
- Ketoconazole, an antifungal
- Verapamil, a blood pressure and heart rhythm medication
- Cyclosporine, an immune-suppressing drug used after organ transplants
Even grapefruit juice can interfere with colchicine metabolism enough to matter. Cholesterol-lowering statins and fibrates don’t block the same pathways, but they independently raise the risk of muscle damage, compounding colchicine’s own muscle toxicity. If you take colchicine regularly, any new prescription or supplement warrants a conversation about interactions.
What Acute Toxicity Looks Like
Accidental or intentional overdose follows a predictable and dangerous three-stage pattern. In the first stage, beginning within hours of ingestion, severe GI symptoms dominate: intense abdominal pain, vomiting, and profuse diarrhea that leads to significant fluid loss. White blood cell counts may actually spike during this phase.
The second stage, occurring 24 to 72 hours after ingestion, is where life-threatening complications emerge. Breathing can fail due to a combination of respiratory muscle weakness and fluid buildup in the lungs. Bone marrow suppression sets in, and organ damage may follow. In published case series, patients who ingested less than 0.5 mg per kilogram of body weight generally survived, while those who took more than 0.8 mg per kilogram did not. For reference, that upper threshold translates to roughly 56 mg for a 150-pound person, far beyond a normal therapeutic dose of 0.6 to 1.2 mg per day.
A third recovery phase follows for those who survive, but the window between stages two and three is where the greatest danger lies, and there is no antidote for colchicine poisoning. Treatment is entirely supportive.